News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
US Approves Pfizer Inc. Generic of Novartis AG Genotropin
September 3, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG's Omnitrope Pen 10 with liquid cartridge, a copy-cat version of Pfizer Inc's human growth hormone Genotropin.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Pfizer
Novartis
MORE ON THIS TOPIC
FDA
7 FDA decisions to watch for in Q3
July 2, 2026
·
7 min read
·
Tristan Manalac
Approvals
Vertex’s Casgevy becomes first approved gene therapy for young kids with rare blood disorders
July 2, 2026
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH CERTARA
Webinar: Streamlining Nonclinical Development with FDA NAMs
July 1, 2026
·
1 min read
·
BioSpace Insights
Approvals
Orca opens up Treg cell therapy with FDA nod for allogeneic blood cancer treatment
July 1, 2026
·
2 min read
·
Heather McKenzie
